Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement

Patent No. EP2359834 (titled "Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement") was filed by Alexion Pharmaceuticals on Mar 15, 2007. The application was issued on Nov 9, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEAug 9, 2017HOFFMANN EITLE
AMGENAug 4, 2017DORRIES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2359834

ALEXION PHARMACEUTICALS
Application Number
EP11001632A
Filing Date
Mar 15, 2007
Status
Revoked
Feb 23, 2024
Publication Date
Nov 9, 2016